Discovery Series | Infectious Disease
How well are vaccines holding up against SARS-CoV-2 variants?
As SARS-CoV-2 virus variants emerge, new questions in the worldwide pandemic response are also emerging: What protection do vaccines provide against SARS-CoV-2 variants in terms of infection and disease severity?
In a recent study of the Johnson & Johnson vaccine’s efficacy against variants, researchers used immunoSEQ® T-MAP™ COVID to show that, despite a diminished neutralizing antibody response, vaccine-induced T-cell targeting of SARS-CoV-2 antigens was largely unaffected by mutations in the new variants. The latest evidence on the highly infectious Omicron variant suggests that mutations do not affect 70-80% of previously identified antigen specific T-cell responses to SARS-CoV-2.
COVID-19 Publication Review
In our in-depth COVID-19 publication review, learn more about:
- Detecting the virus and immune response
- Understanding exposure and immunity
- Vaccine and drug development
- Variants and vaccines
- COVID-19’s impact on autoimmune disease
- COVID-19’s impact on oncology
Featured webinar:
Harlan Robins (Adaptive CSO) discusses the T-cell response to COVID-19, vaccination, and variants
The emergence of SARS-CoV-2 variants makes understanding the immune system’s interaction with the virus more crucial than ever because current or future variants have the potential to evade the vaccine-induced immune response. Watch the webinar on COVID-19 vaccine research presented by Harlan Robins, Adaptive’s Chief Scientific Officer, featuring a complete index of the topics and audience discussion.
View selected chapters
Additional Resources
Understanding the T-cell response: SARS-CoV-2 variants and vaccine immune response
View the webinar with Harlan Robins on T-cell responses to SARS-CoV-2 variants and vaccination produced with Nature Research Custom Media.
Immunogenicity of AD26.COV2.S vaccine against sars-cov-2 variants in humans
Learn how T-MAP COVID is being used to assess the impact of variants on vaccine efficacy.
Download case study
Effects Of COVID-19 Across Organs And Systems In Healthy And Immunocompromised Individuals
July 2021
View Article
Emerging Themes Around The T-Cell Response & COVID-19: A Look Back At Some Of Our Discussions At World Vaccine Congress 2021
May 2021
View Article
immunoSEQ® T-MAP™ COVID: A Tool To Uncover And Monitor The T-Cell Response in COVID-19
February 2021
View article
Access the Publication Review
Please fill out the form below to download the content
COVID-19 Applications
Learn how immunoSEQ® T-MAP™ COVID can help uncover the T-cell immune response in COVID-19.
Learn More
Contact Us
Looking for more information? Help with experimental design or technical support? Interested in speaking to someone?
Contact Us
Resources
Access technical documents for getting started with the immunoSEQ® Service product, grant writing support, and FAQs.
Learn More